SARAJEVO (Bosnia and Herzegovina), September 19 (SeeNews) – Bosnia’s biggest pharmaceutical company, blue chip Bosnalijek, said on Friday it has indefinitely postponed plans for a new share issue because of the unfavourable market situation.